ArticleParasites & vectors2026
Molecular mechanisms of simvastatin response in Mesocestoides corti: a proteomic approach to drug repurposing for larval cestodiases.
Article in Parasites & vectors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Larval cestodiases remain difficult to treat, highlighting the need for novel therapeutic targets. The mevalonate pathway, essential for isoprenoid biosynthesis and cellular homeostasis, represents a promising target in cestodes. Previous studies demonstrated that simvastatin impairs the viability and motility of Mesocestoides corti tetrathyridia in vitro. Here, we investigated the proteomic response of M. corti larvae to simvastatin exposure (60.29 and 100 µM) using DIA-based proteomics. A total of 3,378 proteins were identified, with 19 showing differential abundance across treatments. Proteomic and Gene Ontology enrichment analyses revealed dose-dependent alterations associated mainly with structural organization, metabolism, intracellular transport, and stress-related processes. Although no clear proteomic signature of cell death was detected, simvastatin induced adaptive responses consistent with compensatory remodeling in response to pharmacological stress. These findings support the biological relevance of the mevalonate pathway in cestode survival and reinforce HMG-CoA reductase as a potential target for drug repurposing strategies against larval cestodiases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.